Pharma Industry News

CureVac snags new Gates Foundation backing for universal flu, malaria mRNA vaccine work

Written by David Miller

The Bill & Melinda Gates Foundation left open the possibility for additional funding when it made a $52 million equity investment in CureVac in 2015. Now, the foundation is offering two new grants to develop mRNA vaccines against influenza and malaria.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]